Sean Brynjelsen

Amministratore Delegato presso ETON PHARMACEUTICALS, INC.

Patrimonio netto: 3 M $ in data 30/04/2024

52 anni

Health Technology

Consumer Services

Posizioni attive di Sean Brynjelsen

Società	Posizione	Inizio	Fine
ETON PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	01/06/2017	-
	Amministratore Delegato	01/06/2017	-
	Presidente	01/06/2017	-

Società	Posizione	Inizio	Fine
SAGENT PHARMACEUTICALS INC	Corporate Officer/Principal	23/03/2016	01/06/2017
AKORN, INC.	Direttore Tecnico/Scientifico/R&S	18/06/2010	07/02/2014
AKORN, INC.	Corporate Officer/Principal	07/02/2014	01/03/2016

University of Notre Dame	Masters Business Admin
University of Illinois	Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Masters Business Admin	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ETON PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Akorn, Inc. Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.	Health Technology
Sagent Pharmaceuticals, Inc. Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.	Health Technology

Aziende private

Health Technology